Natraj Proteins Q2 FY27 Profit Turns Positive Despite Sales

Profit returns despite lower revenue

Natraj Proteins Limited reported a standalone net profit of ₹34.50 lakh for the quarter ended September 30, 2026, marking a reversal from a net loss of ₹164.98 lakh in the corresponding quarter of the previous year. The Itarsi-based agri-business company achieved the turnaround even as revenue from operations declined year-on-year. Revenue from operations stood at ₹1,820.15 lakh in Q2 FY27, compared with ₹2,692.17 lakh in Q2 FY26. This represents a decline of 32.4%.

The quarter therefore showed a clear divergence between sales and profitability. A lower top line did not prevent the company from moving back into profit. Based on the reported context, the improvement was supported by lower costs of materials consumed and reduced purchases of stock-in-trade. The result places cost control and inventory management at the centre of the company’s quarterly performance.

Q2 FY27 financial snapshot

The reported numbers show a significant improvement in the bottom line from a year earlier. Net profit moved from a loss of ₹164.98 lakh to a profit of ₹34.50 lakh. That is a positive swing of ₹199.48 lakh in reported net earnings. At the same time, revenue fell by ₹872.02 lakh from the year-ago level.

The numbers indicate that the company’s quarterly profit recovery was not linked to revenue expansion. Instead, the lower cost base appears to have outweighed the reduction in revenue. The available information does not provide a segment-wise or product-wise revenue breakup.

Cost control drives the turnaround

Natraj Proteins attributed the profitability improvement to significantly lower costs of materials consumed and purchases of stock-in-trade. These two expense lines are particularly relevant for an agri-business, where procurement and inventory costs can have a direct effect on margins. A reduction in these costs can improve earnings even when sales are lower.

The reported outcome suggests that the company managed its operating inputs more tightly during the quarter. Lower material consumption and lower stock-in-trade purchases reduced the pressure created by the revenue decline. However, the figures provided do not specify the individual value of these expenses, their percentage reduction, or the factors behind the change. As a result, the full composition of the margin improvement is not available from the reported data.

Revenue contraction remains material

The 32.4% decline in revenue from operations remains the central operational feature of the quarter. Revenue fell to ₹1,820.15 lakh from ₹2,692.17 lakh a year earlier. The decline shows that the profit improvement was achieved on a substantially smaller revenue base.

This distinction matters because lower costs and lower sales can occur together when procurement, inventory levels, or business activity are adjusted. The company’s reported result demonstrates that profitability can improve through tighter cost management, but it does not establish whether the revenue decline was temporary or part of a broader sales trend. No volume, pricing, customer, or product data was provided to explain the fall in revenue.

Margin improvement was not sales-led

The inverse relationship between revenue and net profit is the defining aspect of Natraj Proteins’ Q2 FY27 result. Revenue contracted by more than 32%, while the company moved from a loss to a profit. This means the improvement was not driven by higher sales volumes or stronger pricing, based on the information available.

Instead, the reported facts point towards aggressive inventory management and cost control. Reduced spending on materials consumed and stock-in-trade purchases appears to have helped protect profitability. For investors, this makes the sustainability of the lower cost base an important consideration in evaluating future results. The company has not provided further details in the supplied information on whether these cost reductions are expected to continue.

FY26 provides recent financial context

The Q2 FY27 result follows a return to annual profitability in FY26. Natraj Proteins reported net profit of ₹113.51 lakh for FY26, compared with a net loss of ₹146.27 lakh in the previous year. Annual income from operations stood at ₹10,112.13 lakh.

The FY26 performance itself came with lower revenue. Revenue from operations was reported at ₹10,112.13 lakh, versus ₹11,827 lakh in FY25, a decline of 14.27% on the stated comparison. Yet the company reversed the previous year’s loss at the annual level. This pattern provides background to the latest quarter, where profit recovery has again occurred alongside lower revenue.

Recent quarterly performance

Natraj Proteins reported net profit of ₹211 lakh on sales of ₹3,142 lakh for the quarter ended June 2026. Sales were up 18.3% from ₹2,656 lakh in the corresponding quarter a year earlier, according to the supplied quarterly data. The June quarter was therefore stronger on both sales and profit than the September quarter’s reported revenue level.

For the March 2026 quarter, the company reported net profit of ₹110.84 lakh and total income of ₹1,887.26 lakh. The March quarter followed a reported profit of ₹289 lakh in the December 2025 quarter. These historical quarterly figures show that earnings and revenue have varied across periods, while the latest result adds another instance where profitability was influenced by cost management.

What the result means for investors

The Q2 FY27 update offers two contrasting signals. The return to a ₹34.50 lakh standalone profit is a clear improvement from the ₹164.98 lakh loss recorded a year earlier. But the decline in revenue from operations to ₹1,820.15 lakh highlights the reduced scale of business during the quarter.

The result is therefore best assessed through both measures rather than the profit number alone. The reported reduction in material and inventory-related costs helped restore profitability. At the same time, future disclosures on revenue movement, procurement costs, inventory levels, and operating expenses will be relevant to understanding whether this improvement can be sustained.

Conclusion

Natraj Proteins delivered a profit turnaround in Q2 FY27 despite a 32.4% fall in revenue from operations. The company’s reported lower material and stock-in-trade costs were the main support for the recovery from a year-ago loss. The next reported quarterly update will provide further evidence on revenue trends and the durability of the cost-led margin improvement.